What happened
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
SourceEuropean Organization for Nuclear ResearchpublicationBiotech
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
Publication signal: MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceEuropean Organization for Nuclear ResearchLimitations
AISci rank score does not assess scientific quality or citation impact.
SourceEuropean Organization for Nuclear ResearchLinked output
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 ManagementpaperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
MetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management
Diagnostics and Biomarkers
Controlled AISci Stage A topic for Diagnostics and Biomarkers.
Timeline
- publicationMetaboCovid-19: Metabolomics and Artificial Intelligence for Precision Medicine in COVID-19 Management